Abstract: A precursor having at least five percent of lignin based coke and d002 spacing of more than 3.36 angstroms and less 3.44 for making graphite. Methods for making a green/graphite article include mixing coke derived from a petroleum product, a coal product or a bitumen product with coke derived from lignin. Alternatively, the precursor material for the various types of coke may be mixed and coked together. The mixture may be formed into a desired shape. The article may be subsequently carbonized and graphitized. The amount of lignin derived coke comprises a sufficient quantity to change at least a selected property of the graphite article.

Abstract: The invention relates to a high pressure diaphragm compressor for pressurizing a gaseous fluid to a pressure of at least 10 MPa, the compressor including a compressor head having an oblong shaped chamber.

Abstract: Inflammatory and other cellular response-modulating compositions are provided comprising aminoacyl-tRNA synthetase polypeptides, including active fragments and/or variants thereof. Also provided are methods of using such compositions in the treatment of conditions that benefit from the modulation of inflammation, such as inflammatory diseases or conditions.

Abstract: A method and apparatus model multiple relationship dimensions among a set of entities is presented. A computer system identifies a configuration for the structure. The configuration comprises metadata about supported relationship aspects for the set of entities within a structure context. The computer system identifies aspects for an entity according to the structure context. The entity aspects comprise metadata about relationships for the entity within the structure context. The computer system compares the entity aspects to the configuration for the structure to determine a relationship of the entity to the set of entities. The computer system dynamically attaches the entity to the set of entities according to the determined relationship to form the structure.

Abstract: The present invention provides aspartyl-tRNA synthetase derived proteins (DRS polypeptides) with altered cysteine content, compositions comprising the same, and methods of using such polypeptides and compositions for treating or diagnosing a variety of conditions. The DRS polypeptides of the invention have immunomodulatory properties, and exhibit improved activity and stability.

Abstract: Isolated glycyl-tRNA synthetase polypeptides and polynucleotides having non-canonical biological activities are provided, as well as compositions and methods related thereto.

Abstract: Inflammatory and other cellular response-modulating compositions are provided comprising aminoacyl-tRNA synthetase polypeptides, including active fragments and/or variants thereof. Also provided are methods of using such compositions in the treatment of conditions that benefit from the modulation of inflammation, such as inflammatory diseases or conditions.

Abstract: The present invention provides aspartyl-tRNA synthetase and Fc region conjugate polypeptides (DRS-Fc conjugates), such as DRS-Fc fusion proteins, compositions comprising the same, and methods of using such conjugates and compositions for treating or diagnosing a variety of conditions. The DRS-Fc conjugates of the invention have improved controlled release properties, stability, half-life, and other pharmacokinetic and biological properties relative to corresponding, unmodified DRS polypeptides.

Abstract: Described herein is a method and system for encoding video data. The design comprises a two pass encoding system with bi-direction control to and from a classification engine. In the first pass coder, a future picture is encoded to produce a set of parameters that characterize the future picture. In the second pass coder a current picture is encoded to produce a video output. The classification engine is the center of perceptual enhancement. The classification engine interprets the set of parameters from the first pass coder and classifies the current picture.

Abstract: Isolated glycyl-tRNA synthetase polypeptides and polynucleotides having non-canonical biological activities are provided, as well as compositions and methods related thereto.

Abstract: Inflammatory and other cellular response-modulating compositions are provided comprising aminoacyl-tRNA synthetase polypeptides, including active fragments and/or variants thereof. Also provided are methods of using such compositions in the treatment of conditions that benefit from the modulation of inflammation, such as inflammatory diseases or conditions.

Abstract: An assembly for use in a rotor of a turbine generator is provided that includes at least one creepage disposed on an upper load surface of copper windings. At least one slot spring is disposed on the creepage, and at least one amortisseur is disposed on the slot spring. A plurality of hollow locking members are disposed within apertures of the creepage, the slot spring, and the amortisseur. At least one slot wedge is disposed on the slot spring and the plurality of hollow locking members. At least one field retaining ring is disposed against one of the end portions of the rotor body and against the slot wedge.

Abstract: A precursor having at least five percent of lignin based coke and d002 spacing of more than 3.36 angstroms and less 3.44 for making graphite. Methods for making a green/graphite article include mixing coke derived from a petroleum product, a coal product or a bitumen product with coke derived from lignin. Alternatively, the precursor material for the various types of coke may be mixed and coked together. The mixture may be formed into a desired shape. The article may be subsequently carbonized and graphitized. The amount of lignin derived coke comprises a sufficient quantity to change at least a selected property of the graphite article.

Abstract: Inflammatory and other cellular response-modulating compositions are provided comprising aminoacyl-tRNA synthetase polypeptides, including active fragments and/or variants thereof. Also provided are methods of using such compositions in the treatment of conditions that benefit from the modulation of inflammation, such as inflammatory diseases or conditions.

Abstract: Isolated glycyl-tRNA synthetase polypeptides and polynucleotides having non-canonical biological activities are provided, as well as compositions and methods related thereto.

Abstract: A transceiver includes an integrated circuit that enables board-level configuration of an on-chip or external transmit/receive switch. The transceiver uses a high-Q matching network, at least part of which is external, that improves receiver performance; increases transmit power while allowing for configuration of the same chip to use an internal TR switch, or external TR switch by changing connection at the board level rather than the chip level.

Abstract: Isolated glycyl-tRNA synthetase polypeptides and polynucleotides having non-canonical biological activities are provided, as well as compositions and methods related thereto.

Abstract: Inflammatory and other cellular response-modulating compositions are provided comprising aminoacyl-tRNA synthetase polypeptides, including active fragments and/or variants thereof. Also provided are methods of using such compositions in the treatment of conditions that benefit from the modulation of inflammation, such as inflammatory diseases or conditions.

Abstract: A method of making a carbon fiber includes heat treating a lignin precursor absent an active ingredient in an inert atmosphere to raise the glass transition temperature (Tg) of the precursor by at least five (5%) percent, forming a lignin precursor having an increased Tg (High Tg Lignin). The High Tg Lignin can be spun into a fiber. The fiber may then be stabilized to form a thermoset fiber. The time period for stabilizing the fiber is less than one hundred (100) hours.

Abstract: Inflammatory and other cellular response-modulating compositions are provided comprising aminoacyl-tRNA synthetase polypeptides, including active fragments and/or variants thereof. Also provided are methods of using such compositions in the treatment of conditions that benefit from the modulation of inflammation, such as inflammatory diseases or conditions.